Table 1.
[normal range] | Pre-operative TMs and CTs | TMs and CTs at POW4 |
---|---|---|
CA19-9 (U/mL) [0.0-37.0] | >12,0000 | 4905.5 |
CEA (ng/mL) [0.0-5.0] | 589.6 | 6.3 |
CA125 (U/mL) [0.0-35.0] | 64.8 | 104.8 |
CA15-3 (U/mL) [0.0-31.3] | 95.4 | 15.3 |
SLX (U/mL) [0.0-38.0] | 330 | 46 |
D-dimer (mg/mL) [0.0-1.0] | 6.2 | 3.2 |
FDP (mg/mL) [0.0-4.9] | 8.5 | 6.2 |
fibrinogen (mg/dL) [200-400] | 438 | 272 |
TM tumor maker, CT coagulation test, POW4 postoperative week 4, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, CA125 cancer antigen 125, CA15-3 Cancer antigen 15-3, SLX Sialyl Lewis X, FDP fibrin degradation product